Respiratory syncytial virus (RSV): Potential significant opportunity for effective vaccine
See on Scoop.it – Virology and Bioinformatics from Virology.ca
Pioneering new research into respiratory syncytial virus (RSV) may have overcome the barriers that have impeded the development
of an effective vaccine against the deadly virus.
RSV is a virus that causes lower respiratory tract infections and is a major cause of childhood morbidity and mortality worldwide. Attempts to develop vaccines against the virus in the 1960s were dogged with disastrous results, with the formalin-inactivated vaccine(FI-RSV) causing the RSV disease to actually worsen in many cases.
See on blogs.terrapinn.com
